Partners agree to share resources, establish steering committee for closer collaboration

On April 20, 2018, Canadian, Chinese and Cuban neuroscience institutes strengthened an existing partnership with the signing of a memorandum of understanding in Chengdu, China.

Partners in the agreement include The Montreal Neurological Institute and Hospital (The Neuro) of McGill University, The Cuban Neuroscience Center, The University of Electronic Sciences and Technology of China, The West China Hospital, and The Tianfu New Area of Chengdu (TFNA).

Classified as: Canada, China, Cuba, dementia, Alzheimer's disease, Research, Partnership, Guy Rouleau
Published on: 23 Apr 2018

2017 Québec Science Discovery of the Year Award goes to the cancer-detection probe developed by Kevin Petrecca and Frédéric Leblond

Québec Science magazine’s 25-year tradition continues: every fall, a jury comprised of researchers and journalists selects the top 10 most impressive discoveries in Quebec in the past year and the public is asked to vote to select the winner. This year, a cancer-detection probe was chosen by nearly a third of approximately 4,400 votes cast in the 2017 Discovery of the Year contest.

Classified as: Kevin Petrecca, Frederic Leblond, cancer probe, raman spectroscopy, Quebec Science, brain cancer, brain tumour, Jason Karamchandani
Published on: 19 Mar 2018

Congratulations to Dr. Carlos Morales, who has been awarded the prestigious Domingo Sarmiento Distinction by the Senate of Argentina for his contributions to medical science.

Published on: 9 Mar 2018

Women scientists and clinicians are creators and changemakers, expanding the boundaries of human knowledge

 

The Neuro has launched Neuro XXceptional - an exciting new year-long video series featuring women who tell us what drove them to become scientists and clinicians, and what they love about their work. At The Neuro, these exceptional professionals are improving the lives of patients, helping us understand how the brain works and how to treat neurological disease.

Classified as: Neuro XXceptional, women in science, Heidi McBride, Lesley Fellows, Brenda Milner
Published on: 8 Mar 2018

Canadian Open Neuroscience Platform will make disseminating and publishing data easier

Modern neuroscience research can produce massive amounts of data, which researchers can use to find patterns revealing anything from the first physiological signs of Alzheimer’s disease to a new drug target that could stop neurodegeneration. However, this data must be stored, processed, and distributed effectively.

Classified as: neuroinformatics, Alan Evans, CONP, Canadian Open Neuroscience Platform, Brain Canada, Guy Rouleau
Published on: 19 Feb 2018

Message posted on behalf of the Faculty of Medicine

Starting Monday February 12th, 2018, the opening hours for the McIntyre Medical Building 3rd floor study space will be extended weekly at night until 20:30 from Monday to Thursday ONLY.

The opening hours are as follows: 

- Monday to Thursday from 09:00 to 20:30

- Friday from 09:00 to 17:00

Classified as: Opening hours
Published on: 8 Feb 2018

Volume in brain region linked to physiological changes characteristic of AD

New research has drawn a link between changes in the brain’s anatomy and biomarkers that are known to appear at the earliest stages of Alzheimer’s disease (AD), findings that could one day provide a sensitive but non-invasive test for AD before cognitive symptoms appear.

Classified as: Alzheimer's disease, AD, MRI, Christine Tardif, Mallar Chakravarty, Douglas Institute
Published on: 19 Dec 2017

NeuroSGC created to increase volume and quality of cell assays for drug discovery

A new partnership between the Structural Genomics Consortium (SGC) and the Montreal Neurological Institute and Hospital (The Neuro) will use a unique open science framework to help scientists discover new targets for drug development for neurological diseases.

The partnership, called NeuroSGC, will initially focus on Parkinson’s disease and amyotrophic lateral sclerosis (ALS), two of the most common neurodegenerative diseases.

Classified as: open science, MNI, Guy Rouleau
Published on: 6 Dec 2017

Industry and academia team up for the benefit of people suffering from ALS

A unique industry-academia partnership will increase the rate at which promising drug compounds can be tested as potential treatments for amyotrophic lateral sclerosis (ALS), a disease with no known cure that affects 200,000 people worldwide.

The partnership between The Montreal Neurological Institute and Hospital (MNI) and Takeda Pharmaceutical Company Limited (Takeda) will allow compounds developed by Takeda scientists to be tested on cell lines produced at the MNI.

Classified as: Takeda, stem cells, ALS, hiPSCs, amyotrophic lateral sclerosis, open science, C-BIGR, Thomas Durcan, Edward Fon, Guy Rouleau
Published on: 4 Dec 2017

Brain stimulation can change how much we enjoy and value music

Enjoyment of music is considered a subjective experience; what one person finds gratifying, another may find irritating. Music theorists have long emphasized that although musical taste is relative, our enjoyment of music, be it classical or heavy metal, arises, among other aspects, from structural features of music, such as chord or rhythm patterns that generate anticipation and expectancy.

Classified as: music, Robert Zatorre, Ernest Mas Herrero, fronto-striatal circuits, TMS, transcranial magnetic stimulation
Published on: 20 Nov 2017

The Azrieli Centre for Autism Research will foster innovations in therapy and a better understanding of Autism Spectrum Disorder.

A new research centre in Montreal will help lift the shroud of mystery surrounding autism spectrum disorder (ASD), and lead to the development of better diagnostic tools and more effective therapies for people with autism.

Classified as: autism, Azrieli Centre for Autism Research, Azrieli Foundation, Guy Rouleau, ACAR Stories
Published on: 23 Oct 2017

A Brilliant Night has donated a total of $1.6 million since 2015

A night dedicated to the memory of those lost to brain cancer and in honour of those still fighting the disease will raise money for research that will lead to better treatments.

Classified as: a brilliant night, Kevin Petrecca, brain cancer, brain tumour
Published on: 10 Oct 2017

Research shows how the brain’s motor signals sharpen our ability to decipher complex sound flows

Whether it is dancing or just tapping one foot to the beat, we all experience how auditory signals like music can induce movement. Now new research suggests that motor signals in the brain actually sharpen sound perception, and this effect is increased when we move in rhythm with the sound.

Classified as: Motor signals, Sound perception, Benjamin Morillon, Sylvain Baillet
Published on: 5 Oct 2017

Discovery points to possible target for cancer drugs

McGill University researchers have discovered a mechanism through which mitochondria, the energy factory of our body’s cells, play a role in preventing cells from dying when the cells are deprived of nutrients – a finding that points to a potential target for next-generation cancer drugs.

The research, published in Molecular Cell, builds on previous work by McGill professor Nahum Sonenberg, one of the senior authors of the new study.

Classified as: Heidi McBride, mitochondria
Published on: 22 Sep 2017

Research symposium, public education event and ALS walk planned

Multiple events planned for this week will help educate the public about amyotrophic lateral sclerosis (ALS), a devastating disease that still has no cure.

Classified as: ALS research, ALS, ALS awareness, Research symposium, ALS walk, Neuro, Dr. Angela Genge, ALS Society of Quebec
Published on: 13 Sep 2017

Pages

Back to top